Amylyx Pharmaceuticals, Inc. (AMLX)
14.10
-0.95
(-6.31%)
USD |
NASDAQ |
Mar 05, 16:00
14.10
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Cash from Investing (Quarterly) : 29.47M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Rapt Therapeutics, Inc. | 8.466M |
| Disc Medicine, Inc. | -222.89M |
| Cytokinetics, Inc. | -71.19M |
| Ionis Pharmaceuticals, Inc. | -419.50M |
| MediciNova, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.90M |
| Cash from Financing (Quarterly) | -0.208M |
| Free Cash Flow | -123.48M |
| Free Cash Flow Per Share (Quarterly) | -0.2548 |
| Free Cash Flow to Equity (Quarterly) | -28.01M |
| Free Cash Flow to Firm (Quarterly) | -27.99M |
| Free Cash Flow Yield | -9.27% |